ID19469A - Pemakaian turunan teofilin untuk mengobati dan mencegah penyakit keadaan shock, senyawa ksantin yang baru dan proses pembuatannya - Google Patents

Pemakaian turunan teofilin untuk mengobati dan mencegah penyakit keadaan shock, senyawa ksantin yang baru dan proses pembuatannya

Info

Publication number
ID19469A
ID19469A IDP971930A ID971930A ID19469A ID 19469 A ID19469 A ID 19469A ID P971930 A IDP971930 A ID P971930A ID 971930 A ID971930 A ID 971930A ID 19469 A ID19469 A ID 19469A
Authority
ID
Indonesia
Prior art keywords
thefillin
ksantin
theory
treat
compounds
Prior art date
Application number
IDP971930A
Other languages
English (en)
Inventor
Ulrich Dr Gebert
Erhard Dr Wolf
Elisabeth Dr Defossa
Uwe Dr Heinelt
Db Hiristo Anagnostopulos
Karl Dr Rudolphi
John J Dr Grome
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19622737A external-priority patent/DE19622737A1/de
Priority claimed from DE1996129815 external-priority patent/DE19629815A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ID19469A publication Critical patent/ID19469A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IDP971930A 1996-06-07 1997-06-05 Pemakaian turunan teofilin untuk mengobati dan mencegah penyakit keadaan shock, senyawa ksantin yang baru dan proses pembuatannya ID19469A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19622737A DE19622737A1 (de) 1996-06-07 1996-06-07 Verwendung von Theophyllinderivaten zur Behandlung und Prophylaxe von Schockzuständen, neue Xanthinverbindungen und Verfahren zu deren Herstellung
DE1996129815 DE19629815A1 (de) 1996-07-24 1996-07-24 Verwendung von Theophyllinderivaten zur Behandlung und Prophylaxe von Schockzuständen, neue Xanthinverbindungen und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
ID19469A true ID19469A (id) 1998-07-16

Family

ID=26026372

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971930A ID19469A (id) 1996-06-07 1997-06-05 Pemakaian turunan teofilin untuk mengobati dan mencegah penyakit keadaan shock, senyawa ksantin yang baru dan proses pembuatannya

Country Status (26)

Country Link
US (1) US6214992B1 (id)
EP (1) EP0812844B1 (id)
JP (1) JP4156687B2 (id)
KR (1) KR100477177B1 (id)
CN (1) CN1066146C (id)
AR (1) AR007506A1 (id)
AT (1) ATE226583T1 (id)
AU (1) AU712277B2 (id)
BR (1) BR9703499A (id)
CA (1) CA2207120C (id)
CZ (1) CZ292205B6 (id)
DE (1) DE59708533D1 (id)
DK (1) DK0812844T3 (id)
ES (1) ES2185837T3 (id)
HU (2) HU224958B1 (id)
ID (1) ID19469A (id)
IL (1) IL120997A (id)
MX (1) MX9704203A (id)
MY (1) MY117910A (id)
NO (1) NO312400B1 (id)
NZ (1) NZ328017A (id)
PL (1) PL186576B1 (id)
PT (1) PT812844E (id)
RU (1) RU2201930C2 (id)
SI (1) SI0812844T1 (id)
TW (1) TW520285B (id)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9703044D0 (en) 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
GB9817623D0 (en) 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
FR2804867B1 (fr) * 2000-02-15 2002-09-20 Hoechst Marion Roussel Inc Application de derives de xanthine pour la preparation d'un medicament destine a la prevention ou au traitement de l'osteoporose
FR2804958B1 (fr) * 2000-02-15 2005-07-08 Hoechst Marion Roussel Inc Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
UA80258C2 (en) * 2001-09-06 2007-09-10 Biogen Inc Methods of treating pulmonary disease
JP2005529934A (ja) * 2002-05-31 2005-10-06 シェーリング コーポレイション キサンチンホスホジエステラーゼvインヒビターおよびその前駆物質を調製するプロセス
SI1509525T1 (sl) * 2002-05-31 2006-12-31 Schering Corp Postopek priprave inhibitorjev ksantinske fosfodiesteraze V in njihovih prekurzorjev
CN112500413B (zh) * 2020-10-13 2024-03-01 安徽中医药大学 一类黄嘌呤芳酸醚衍生物,其制备方法及用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735898A (en) 1985-07-16 1988-04-05 The University Of Virginia Alumini Patents Foundation Monoclonal antibodies and method of identifying species using the same
US4904472A (en) * 1987-04-10 1990-02-27 The University Of Virginia Alumni Patent Foundation Use of adenosine antagonists in the treatment of bradyarrhythmias and mechanical dysfunction associated with cardiopulmonary resuscitation
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
JPH03167186A (ja) * 1989-11-24 1991-07-19 Hokuriku Seiyaku Co Ltd キサンチン誘導体及びその用途
US5036683A (en) * 1990-06-04 1991-08-06 Geuvjehizian Moushegh Y Steering wheel lock protector
DE4019571A1 (de) * 1990-06-20 1992-01-02 Hoechst Ag Pharmazeutische kombinationspraeparate enthaltend cephalosporin- und xanthinderivate und deren verwendung
DE19540798A1 (de) * 1995-11-02 1997-05-07 Hoechst Ag Alkylxanthinphosphonate und Alkylxanthinphosphinoxide und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
EP0812844A2 (de) 1997-12-17
MY117910A (en) 2004-08-30
HU9701016D0 (en) 1997-07-28
ES2185837T3 (es) 2003-05-01
AU712277B2 (en) 1999-11-04
TW520285B (en) 2003-02-11
IL120997A0 (en) 1997-11-20
HUP9701016A3 (en) 2004-11-29
NZ328017A (en) 2001-05-25
PL186576B1 (pl) 2004-01-30
SI0812844T1 (en) 2003-02-28
HUP9701016A2 (hu) 1998-12-28
CZ174397A3 (en) 1997-12-17
PT812844E (pt) 2003-03-31
EP0812844B1 (de) 2002-10-23
US6214992B1 (en) 2001-04-10
IL120997A (en) 2001-06-14
NO312400B1 (no) 2002-05-06
HU225040B1 (en) 2006-05-29
CN1066146C (zh) 2001-05-23
HU224958B1 (en) 2006-04-28
ATE226583T1 (de) 2002-11-15
DK0812844T3 (da) 2003-02-17
NO972582D0 (no) 1997-06-06
CA2207120A1 (en) 1997-12-07
NO972582L (no) 1997-12-08
PL320413A1 (en) 1997-12-08
MX9704203A (es) 1998-04-30
JPH1059969A (ja) 1998-03-03
EP0812844A3 (de) 1998-04-08
CN1169993A (zh) 1998-01-14
KR100477177B1 (ko) 2005-09-30
BR9703499A (pt) 1998-10-06
CZ292205B6 (cs) 2003-08-13
RU2201930C2 (ru) 2003-04-10
AR007506A1 (es) 1999-11-10
DE59708533D1 (de) 2002-11-28
JP4156687B2 (ja) 2008-09-24
AU2469897A (en) 1997-12-11
KR980008230A (ko) 1998-04-30
CA2207120C (en) 2007-05-08
HU0500865D0 (en) 2005-11-28

Similar Documents

Publication Publication Date Title
ID26589A (id) 4-haloalkil -3-heterosiklilpiridina dan 4- haloalkil-5-heterosiklilpirimidina proses untuk pembuatannya komposisi yang terdiri darinya dan pemakaiannya sebagai pestisida
ID23557A (id) Poliester baru dan proses pembuatan poliester
ID17524A (id) Proses pemanfaatan penyerapan tekana vakum ayun
ID22490A (id) Benzamida-benzamida yang disubstitusi secara heterosiklik yang baru dan penggunaannya
ID15881A (id) Oksazolidinan tersubstitusi yang baru
ID23018A (id) Proses baru untuk pembuatan zat-zat yang aktif secara farmakologi
ID26207A (id) ESTRATRIENA TERSUBSTITUSI 11β-HALOGEN-7 αTERSUBSTITUTASI, PROSES UNTUK MEMPRODUKSI SEDIAAN FARMASI YANG MENGANDUNG ESTRATRIENA 11β-HALOGEN-7 αINI DAN JUGA PENGGUNAANNYA UNTUK PRODUKSI ZAT-ZAT FARMASI
ID25608A (id) Struktur selulosa dengan kerapatan yang berbeda dan proses pembuatannya
ID25469A (id) Komposisi sefalosporin amorf yang stabil secara kristalografi dan proses pembuatannya
ID25516A (id) Senyawa-senyawa yang mengandung cincin-cincin beranggotakan enam, proses pembuatannya, dan penggunaannya sebagai obat
ID27663A (id) Getah karet alam hipoallergenik dan proses pembuatannya
ID17360A (id) Proses pembuatan logam silikat kristalin mikropori dan mesopori, produk yang dapat diperoleh dengan proses tersebut dan penggunaannya
ID20604A (id) Polisakarida sintetis proses untuk pembuatan dan komposisi farmasi yang dikandungnya
ID20137A (id) Turunan propanolamina, proses pembuatannya, sediaan farmasi yang mengandung senyawa ini, dan penggunannya
ID24070A (id) Katalis yang mengandung hologen dan proses pembuatannya
ID24600A (id) Proses pembuatan poliol-poliol polieter dan poliol yang dibuat bersamaan
ID19469A (id) Pemakaian turunan teofilin untuk mengobati dan mencegah penyakit keadaan shock, senyawa ksantin yang baru dan proses pembuatannya
ID21999A (id) Proses baru
ID18954A (id) Kopolimer, proses terhidrogenasi daripadanya, dan proses untuk memproduksinya
NO995723L (no) Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer
ID22398A (id) Proses pembuatan turunan-turunan tiazol
ID19050A (id) Turunan-turunan asam karboksilat yang baru, pembuatannya dan penggunaannya
DE69519602D1 (de) Kugelförmige Aktivkohle zur Behandlung von Hämorrhoiden
ID23175A (id) Penggunaan benzopiranol untuk mengobati gangguan syaraf
ID26660A (id) Proses pembuatan butana-1,4-diol, gamma-butirolakton dan tetrahidrofuran